Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
Launched by HVIDOVRE UNIVERSITY HOSPITAL · Jun 26, 2020
Trial Information
Current as of June 24, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Scheduled for endoscopic or laparoscopic sleeve at Hvidovre Hospital
- • HbA1c \< 48 mmol/mol before surgery, and no history of diabetes
- • HbA1c \< 48 mmol/mol and fasting plasma glucose \< 6.1 mmol/l at inclusion
- • BMI\<45
- Exclusion Criteria:
- • Hemoglobin \< 6.5 mmol/l at inclusion
- • Pregnancy or breast feeding
- • Medication affecting the planned examinations
About Hvidovre University Hospital
Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Hvidovre, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials